MRs. Cumulative incidence for (A) achievement of confirmed MMR (BCR-ABL1 ≤0.1% on 2 successive occasions) and (B) confirmed CMR. Point estimates are 60.9% (95% CI, 53.9% to 67.2%) at 12 months and 78.1% (95% CI, 71.8% to 83.1%) at 24 months for MMR. Point estimates are 9.0% (95% CI, 5.6% to 13.4%) at 12 and 25.2% (95% CI, 19.6% to 31.3%) at 24 months for CMR. Differences in visit window definition may contribute to the differences in the point estimates of confirmed MMR and CMR as measured by the cumulative incidence function noted in Table 2.